This study proposes a prospective observational registry study involving patients who have undergone clinical MCD testing at Mayo Clinic or referred to Mayo Clinic with Multi-Cancer Detection (MCD) test results for further evaluation and management.Novel, high-performance genomic technologies now allow detection of signals from cancers in the blood, giving rise to a new paradigm of MCD tests. Blood is inherently well suited for detection of cancer biomarkers as it contains circulating tumor cells and tumor cell-free DNA (cfDNA) that have been "shed" from an occult asymptomatic developing cancer. MCD tests analyze these genomic features of the circulating DNA, distinguish it from background signals and determine a site of tumor origin to guide subsequent testing to establish a firm cancer diagnosis (hopefully pre-symptomatic early stage and highly curable).
Cancer
This study proposes a prospective observational registry study involving patients who have undergone clinical MCD testing at Mayo Clinic or referred to Mayo Clinic with Multi-Cancer Detection (MCD) test results for further evaluation and management.Novel, high-performance genomic technologies now allow detection of signals from cancers in the blood, giving rise to a new paradigm of MCD tests. Blood is inherently well suited for detection of cancer biomarkers as it contains circulating tumor cells and tumor cell-free DNA (cfDNA) that have been "shed" from an occult asymptomatic developing cancer. MCD tests analyze these genomic features of the circulating DNA, distinguish it from background signals and determine a site of tumor origin to guide subsequent testing to establish a firm cancer diagnosis (hopefully pre-symptomatic early stage and highly curable).
Multi-Cancer Detection Observational Cohort Study
-
Mayo Clinic in Arizona, Scottsdale, Arizona, United States, 85259
Mayo Clinic in Florida, Jacksonville, Florida, United States, 32224-9980
Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to
ALL
Yes
Mayo Clinic,
Jewel Samadder, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic
2029-06-30